ea0098b10 | Basic Science | NANETS2023
Guenter Rachael
, Chen Weisheng
, Golivi Yuvasri
, Robledo Mario
, Jaskula-Sztul Renata
, Chen Herbert
, Rose Bart
Background: The 5-year survival rate for patients with advanced pancreatic neuroendocrine tumors (pNETs) is less than 30%. Notch signaling is a transmembrane receptor pathway with four distinct isoforms, activation of which is linked to cellular differentiation, cell fate, and viability. Both Notch1 and Notch3 signaling have been shown to be dysregulated in pNETs. Notch3 activation has been shown to repress Notch1 activity in other cancers. We hypothesize that activation of No...